Ryanne Clarke
Family · Gretna, LANPI 1770911406
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $73,839 of the $122,580 with a category attached, or 60.2%. Gilead accounts for 95.6% of it on its own, with 24 other manufacturers making up the rest. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 525 payments — averaging $233.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$117K
- Viiv Healthcare Company$2K
- Merck$432
- AbbVie$300
- Abbott$290
- Johnson & Johnson$257
- plus $2K from 19 others
What the payments were for
- Consulting fees$5,6905%
- Speaking & faculty fees$73,83960%
- Travel & lodging$30,44925%
- Food & beverage$12,59110%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 343 | $117,151 |
| Viiv Healthcare Company | 89 | $2,212 |
| Merck | 23 | $432 |
| AbbVie | 16 | $300 |
| Abbott | 2 | $290 |
| Johnson & Johnson | 13 | $257 |
| Novo Nordisk | 2 | $248 |
| Dexcom, Inc. | 2 | $246 |
| Lilly USA, LLC | 5 | $162 |
| Exact Sciences | 4 | $147 |
| Teva Pharmaceuticals USA, Inc. | 1 | $142 |
| Dermavant Sciences, Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Agile Therapeutics, Inc. | 2 | $111 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Pfizer | 4 | $79 |
| Boston Scientific | 1 | $75 |
| Theratechnologies Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $36 |
| Sunovion Pharmaceuticals Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $23 |
| EMD Serono, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biktarvy$54,276
- Descovy$37,898
- Yeztugo$3,840
- DOVATO$470
- CABENUVA$454
- Wegovy$248
- FREESTYLE LIBRE 3$163
- FreeStyle Libre 2$128
- VTAMA$125
- DEXCOM G6 TRANSMITTER$124
- Saxenda$123
- GVOKE HYPOPEN$122
- DUPIXENT$122
- DEXCOM G7 GSS (161)$121
How this compares
$122,580 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 38 | $156,266 |
| DovatoDolutegravir Sodium/Lamivudine | 23 | $53,845 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $318 |
| Pravastatin Sodium | 13 | $174 |
| Fluticasone Propionate | 14 | $140 |
| Amlodipine Besylate | 18 | $114 |
| Hydroxyzine Pamoate | 11 | $53 |
| Glipizide | 11 | $30 |
| Hydrochlorothiazide | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $117,151 | $156,26638 claims |
| Viiv Healthcare CompanyDovato | $2,212 | $53,84523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.
Other family in Gretna
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
- Kimberly RaoAlexandria$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.